A detailed history of Tempus Wealth Planning, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tempus Wealth Planning, LLC holds 15,648 shares of BMY stock, worth $911,183. This represents 0.32% of its overall portfolio holdings.

Number of Shares
15,648
Previous 15,413 1.52%
Holding current value
$911,183
Previous $640,000 26.41%
% of portfolio
0.32%
Previous 0.28%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$39.66 - $51.75 $9,320 - $12,161
235 Added 1.52%
15,648 $809,000
Q2 2024

Jul 25, 2024

BUY
$40.25 - $52.99 $164,823 - $216,994
4,095 Added 36.18%
15,413 $640,000
Q1 2024

Apr 19, 2024

BUY
$47.98 - $54.4 $355,915 - $403,539
7,418 Added 190.21%
11,318 $613,000
Q4 2023

Jan 23, 2024

SELL
$48.48 - $57.85 $630 - $752
-13 Reduced 0.33%
3,900 $200,000
Q3 2023

Oct 31, 2023

SELL
$57.89 - $64.73 $253,326 - $283,258
-4,376 Reduced 52.79%
3,913 $227,000
Q2 2023

Jul 21, 2023

SELL
$63.71 - $70.74 $573 - $636
-9 Reduced 0.11%
8,289 $530,000
Q1 2023

May 08, 2023

SELL
$65.71 - $74.53 $71,623 - $81,237
-1,090 Reduced 11.61%
8,298 $575,000
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $30,952 - $36,652
-452 Reduced 4.59%
9,388 $675,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $567 - $335,252
4,363 Added 79.66%
9,840 $700,000
Q4 2021

Feb 02, 2022

SELL
$53.63 - $62.52 $13,032 - $15,192
-243 Reduced 4.25%
5,477 $341,000
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $49,342 - $53,733
-797 Reduced 12.23%
5,720 $382,000
Q1 2021

Apr 29, 2021

BUY
$59.34 - $66.74 $20,175 - $22,691
340 Added 5.5%
6,517 $411,000
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $40,418 - $45,801
700 Added 12.78%
6,177 $383,000
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $8,614 - $9,546
-150 Reduced 2.67%
5,477 $330,000
Q4 2019

Mar 16, 2020

BUY
$49.21 - $64.19 $276,904 - $361,197
5,627 New
5,627 $361,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tempus Wealth Planning, LLC Portfolio

Follow Tempus Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tempus Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tempus Wealth Planning, LLC with notifications on news.